Ginkgo Bioworks Holdings Inc
NYSE:DNA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.36
71.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc
Revenue
Ginkgo Bioworks Holdings Inc
Revenue Peer Comparison
SHW
IFF
DD
ECL
PPG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
Revenue
$251.5m
|
CAGR 3-Years
49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Revenue
$23.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Revenue
$11.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Revenue
$12.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Revenue
$15.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Revenue
$18B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
Ginkgo Bioworks Holdings Inc
Revenue Breakdown
Breakdown by Geography
Ginkgo Bioworks Holdings Inc
Breakdown by Segments
Ginkgo Bioworks Holdings Inc
|
Total Revenue:
251.5m
USD
|
|
Cell Engineering:
143.5m
USD
|
|
Cell Engineering Revenue:
143.5m
USD
|
|
Biosecurity:
107.9m
USD
|
|
Service:
79m
USD
|
|
Product:
28.9m
USD
|
See Also
What is Ginkgo Bioworks Holdings Inc's Revenue?
Revenue
251.5m
USD
Based on the financial report for Dec 31, 2023, Ginkgo Bioworks Holdings Inc's Revenue amounts to 251.5m USD.
What is Ginkgo Bioworks Holdings Inc's Revenue growth rate?
Revenue CAGR 3Y
49%
Over the last year, the Revenue growth was -47%. The average annual Revenue growth rates for Ginkgo Bioworks Holdings Inc have been 49% over the past three years .
You don't have any saved screeners yet
